Fecal Incontinence Global Market Opportunities and Strategies to 2035

This report describes and explains the fecal incontinence market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global fecal incontinence market reached a value of nearly $2.32 billion in 2025, having grown at a compound annual growth rate (CAGR) of 7.6% since 2020. The market is expected to grow from $2.32 billion in 2025 to $3.22 billion in 2030 at a rate of 6.1%. The market is then expected to grow at a CAGR of 6.8% from 2030 and reach $4.33 billion in 2035.

Growth in the historic period resulted from rising prevalence of gastrointestinal disorders, expanding healthcare infrastructure, increasing prevalence of diabetes and metabolic disorders and growing aging population. Factors that negatively affected growth in the historic period were high testing and treatment costs and lack of standard clinical guidelines.

Going forward, rising prevalence of gastrointestinal disorders, growing adoption of advanced continence care products, increasing government initiatives and favorable reimbursement policies and poor dietary patterns and sedentary lifestyle will drive the growth. Factors that could hinder the growth of the fecal incontinence market in the future include high testing and treatment costs and limited healthcare access in low-income regions.

Market trends for the fecal incontinence market include focus on advancing precision medicine approaches and biotechnology-based clinical research collaborations; focus on the integration of Internet of Things (IoT)-enabled devices, focus on collaborations and digital platform expansions; focus on the adoption of artificial intelligence (AI)-driven and autonomous digital systems and focus on the development of sustainable, environmentally responsible, and circular-economy-aligned incontinence products.

The fecal incontinence market is segmented by product type into absorbent products, anal inserts, electrical stimulation devices and other product types. The absorbent products market was the largest segment of the fecal incontinence market segmented by product type, accounting for 55.6% or $1.29 billion of the total in 2025. Going forward, the electrical stimulation devices segment is expected to be the fastest growing segment in the fecal incontinence market segmented by product type, at a CAGR of 10.2% during 2025-2030.

The fecal incontinence market is segmented by age group into pediatric, adult and geriatric. The adult was the largest segment of the fecal incontinence market segmented by age group, accounting for 53% or $1.23 billion of the total in 2025. Going forward, the geriatric segment is expected to be the fastest growing segment in the fecal incontinence market segmented by age group, at a CAGR of 8.3% during 2025-2030.

The fecal incontinence market is segmented by application into hospitals, clinics, home care settings and other applications. The home care settings market was the largest segment of the fecal incontinence market segmented by application, accounting for 47.2% or $1.09 billion of the total in 2025. Going forward, the home care settings segment is expected to be the fastest growing segment in the fecal incontinence market segmented by application, at a CAGR of 7.8% during 2025-2030.

The fecal incontinence market is segmented by distribution channel into online stores, pharmacies, specialty stores and other distribution channels. The pharmacies market was the largest segment of the fecal incontinence market segmented by distribution channel, accounting for 41.9% or $972.4 million of the total in 2025. Going forward, the online stores segment is expected to be the fastest growing segment in the fecal incontinence market segmented by distribution channel, at a CAGR of 9.3% during 2025-2030.

North America was the largest region in the fecal incontinence market, accounting for 35.7% or $812.5 million of the total in 2025. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the fecal incontinence market will be Asia Pacific and Western Europe where growth will be at CAGRs of 8.2% and 7.3% respectively. These will be followed by Africa and Middle East where the markets are expected to grow at CAGRs of 6.8% and 6.6% respectively.

The global fecal incontinence market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 32.59% of the total market in 2024. Medtronic plc was the largest competitor with a 4.07% share of the market, followed by Coloplast Corp. with 3.90%, Hollister Incorporated with 3.88%, Essity AB with 3.86%, B. Braun Melsungen AG with 3.77%, ConvaTec Group plc with 3.51%, Unicharm Corporation (Lifree) with 3.03%, Ontex Group NV with 2.40%, Laborie Medical Technologies Corp. with 2.08% and Teleflex Inc. (Solesta) with 2.08%.

The top opportunities in the fecal incontinence market segmented by product type will arise in the absorbent products segment, which will gain $450.5 million of global annual sales by 2030. The top opportunities in the fecal incontinence market segmented by age group will arise in the geriatric segment, which will gain $470.5 million of global annual sales by 2030. The top opportunities in the fecal incontinence market segmented by application will arise in the home care settings segment, which will gain $499.2 million of global annual sales by 2030. The fecal incontinence market size will gain the most in the USA at $219.3 million.

Market-trend-based strategies for the fecal incontinence market include advancement of discreet, comfortable and reusable anal insert devices for bowel leakage control, expansion of sacral and tibial nerve electrical stimulation devices for bowel control restoration, shift toward minimally invasive and device-based therapies for management, development of skin-friendly, odor-control and high-absorption wearables and increasing use of digital health tools and remote monitoring for bowel management.

Player-adopted strategies in the fecal incontinence market include focus on strengthening operational capabilities through new product launches, strategic acquisitions and regional expansion initiatives.

To take advantage of the opportunities, the analyst recommends the fecal incontinence companies to focus on advancing discreet self-insertable anal insert devices, focus on expanding neuromodulation device adoption through targeted launches, focus on minimally invasive neuromodulation therapies, focus on advanced absorbent wearables and integrated bowel management, focus on electrical stimulation devices for high-growth expansion, expand in emerging markets, continue to focus on developed markets, focus on expanding multi-channel distribution networks, focus on value aligned and tiered pricing, focus on targeted awareness and education campaigns, focus on personalized engagement and professional outreach, focus on geriatric-centric workforce and caregiver enablement.

This product will be delivered within 3-5 business days.